This document discusses the regulation of herbal drugs in India. It begins by providing background on traditional Indian medicine systems like Ayurveda, Siddha, Unani, Naturopathy and Homeopathy. It then explains that herbal drugs are regulated under the Drug and Cosmetic Act of 1940 and Rules of 1945 in India. The Department of AYUSH is the regulatory authority that issues manufacturing licenses and enforces good manufacturing practices. The document outlines the application process for licenses, facility requirements, and clinical trial guidelines for herbal drugs. It also discusses issues like intellectual property protection of traditional knowledge and the growth of the herbal drug industry in India.
The document discusses regulations for herbal drugs and quality standards. It outlines World Health Organization guidelines for authentication, contaminants testing, and other quality control of herbal drugs. It then describes regulations for herbal drugs in India, the United States, Australia, Canada, and the European Union. It also discusses Schedule T of the Indian Drugs and Cosmetics Act, which lays out good manufacturing practices, and potential interactions between herbal medicines and conventional drugs.
WHO guidelines on herbal drug monitoringKaustav Dey
This presentation points out the various guidelines laid out by World health organization for safe & effective way of monitoring of Herbal Medicine in a pharmacovigilance setting
The WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants provide technical guidance for obtaining quality medicinal plant materials for herbal products classified as medicines. GACP ensures quality control which directly impacts safety and efficacy. The guidelines cover good agricultural practices, collection practices, and objectives like sustainable harvesting levels and appropriate collection techniques. They address issues like obtaining necessary permits, collecting during optimal seasons, ensuring personnel safety, and respecting national regulations to support sustainable cultivation and collection of medicinal plants.
INDIAN AND INTERNATIONAL PATENT LAW AS APPLICABLE TO HERBAL AND NATURAL PRODUCTSTejaswini Chandra
This document discusses intellectual property rights and patent laws related to industrial pharmacognosy. It defines intellectual property rights as protections for an inventor's intellectual creations. Patents provide exclusive rights over an invention for a limited time in exchange for public disclosure. The history of patent law in India traces back to 1911. For an invention to be patentable, it must be novel, involve an inventive step, and have industrial application. Natural products can be patented if they involve new processes, formulations, or uses. International treaties like the Patent Cooperation Treaty allow filing a single international patent application.
Who guidelines on safety monitoring of natural medicinesPharmacy Slides
This document provides guidelines for monitoring the safety of herbal medicines. It discusses that while some see herbal medicines as inherently safe due to being natural, they can still cause adverse effects. It outlines collecting reports on adverse events from healthcare professionals, consumers, manufacturers, and others. It provides guidance on what herbal products should be monitored and how to report suspected adverse reactions, including requesting information like patient identification and descriptions of the adverse reaction. The goal is to support member states in strengthening pharmacovigilance systems to effectively monitor herbal medicine safety.
The document discusses various quality control methods for herbal drugs as outlined by WHO guidelines. It describes tests for powder fineness, foreign matter, macroscopic and microscopic examination, thin layer chromatography, determination of ash, extractable matter, water and volatile matter, volatile oils, bitterness value, haemolytic activity, and tannins. The methods provide quantitative and qualitative analysis of herbal drugs to ensure appropriate quality standards.
Preparation of documents for Export regd..pptxEasy Concept
A manufacturer holding valid license copy in Form-25 & Form-
28 can obtain No Objection Certificate from Zonal/Sub Zonal
offices of Central Drugs Standard Control Organization (CDSCO) for export purpose only for approved/unapproved new Drugs / banned drug from India.
This document discusses stability testing of herbal drugs. Stability is defined as the capacity of a drug to remain within established specifications limits to maintain its identity, quality and purity throughout its retest or expiration period. Stability testing helps determine a product's shelf life and suitable formulations, excipients, and packaging. It ensures product quality and safety for patients. Types of stability studies include physical, chemical, microbiological, and therapeutic stability testing. The document outlines specifications criteria, testing methods like real-time and accelerated testing, protocols, recommended tests for different dosage forms, and factors affecting stability of herbal medicines like physical and chemical instability, complexity, and drug interactions.
The document discusses regulations for herbal drugs and quality standards. It outlines World Health Organization guidelines for authentication, contaminants testing, and other quality control of herbal drugs. It then describes regulations for herbal drugs in India, the United States, Australia, Canada, and the European Union. It also discusses Schedule T of the Indian Drugs and Cosmetics Act, which lays out good manufacturing practices, and potential interactions between herbal medicines and conventional drugs.
WHO guidelines on herbal drug monitoringKaustav Dey
This presentation points out the various guidelines laid out by World health organization for safe & effective way of monitoring of Herbal Medicine in a pharmacovigilance setting
The WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants provide technical guidance for obtaining quality medicinal plant materials for herbal products classified as medicines. GACP ensures quality control which directly impacts safety and efficacy. The guidelines cover good agricultural practices, collection practices, and objectives like sustainable harvesting levels and appropriate collection techniques. They address issues like obtaining necessary permits, collecting during optimal seasons, ensuring personnel safety, and respecting national regulations to support sustainable cultivation and collection of medicinal plants.
INDIAN AND INTERNATIONAL PATENT LAW AS APPLICABLE TO HERBAL AND NATURAL PRODUCTSTejaswini Chandra
This document discusses intellectual property rights and patent laws related to industrial pharmacognosy. It defines intellectual property rights as protections for an inventor's intellectual creations. Patents provide exclusive rights over an invention for a limited time in exchange for public disclosure. The history of patent law in India traces back to 1911. For an invention to be patentable, it must be novel, involve an inventive step, and have industrial application. Natural products can be patented if they involve new processes, formulations, or uses. International treaties like the Patent Cooperation Treaty allow filing a single international patent application.
Who guidelines on safety monitoring of natural medicinesPharmacy Slides
This document provides guidelines for monitoring the safety of herbal medicines. It discusses that while some see herbal medicines as inherently safe due to being natural, they can still cause adverse effects. It outlines collecting reports on adverse events from healthcare professionals, consumers, manufacturers, and others. It provides guidance on what herbal products should be monitored and how to report suspected adverse reactions, including requesting information like patient identification and descriptions of the adverse reaction. The goal is to support member states in strengthening pharmacovigilance systems to effectively monitor herbal medicine safety.
The document discusses various quality control methods for herbal drugs as outlined by WHO guidelines. It describes tests for powder fineness, foreign matter, macroscopic and microscopic examination, thin layer chromatography, determination of ash, extractable matter, water and volatile matter, volatile oils, bitterness value, haemolytic activity, and tannins. The methods provide quantitative and qualitative analysis of herbal drugs to ensure appropriate quality standards.
Preparation of documents for Export regd..pptxEasy Concept
A manufacturer holding valid license copy in Form-25 & Form-
28 can obtain No Objection Certificate from Zonal/Sub Zonal
offices of Central Drugs Standard Control Organization (CDSCO) for export purpose only for approved/unapproved new Drugs / banned drug from India.
This document discusses stability testing of herbal drugs. Stability is defined as the capacity of a drug to remain within established specifications limits to maintain its identity, quality and purity throughout its retest or expiration period. Stability testing helps determine a product's shelf life and suitable formulations, excipients, and packaging. It ensures product quality and safety for patients. Types of stability studies include physical, chemical, microbiological, and therapeutic stability testing. The document outlines specifications criteria, testing methods like real-time and accelerated testing, protocols, recommended tests for different dosage forms, and factors affecting stability of herbal medicines like physical and chemical instability, complexity, and drug interactions.
Regulatory requirements for herbal medicines: Herbal medicines are different from other types of medicines. The approval process is also different from other medicines. AYUSH Ministry given guidelines for approval of herbal medicines.
Query Solved
1. Regulatory requirements for herbal medicines
2. Herbal Medicines ke liye regulatory requirements
3. AYUSH ka important role in Herbal medicines launch
4. D and C act role in Herbal medicines
5. What are important steps to launch herbal medicines
This document provides guidelines for monitoring the safety of herbal medicines. It discusses the importance of including herbal medicines in pharmacovigilance systems to understand adverse effects from combined herbal and conventional medicine use. Sources of safety reports include healthcare professionals, consumers, hospitals, and manufacturers. National regulatory agencies are responsible for communicating safety information through various channels to facilitate safe and effective herbal medicine use.
This document discusses the herbal drug industry in India. It provides an overview of:
- The growing trend toward herbal medicines and India's role as a source of medicinal plants
- The scope and size of the herbal drug market in India, which is growing at 20-25% annually
- Infrastructure requirements for herbal drug manufacturing facilities, including space allocation, environmental factors, and quality control processes
- Good manufacturing practices (GMP) that must be followed to ensure quality standards are met
The document discusses the regulatory status of herbal drugs in India. It outlines that herbal drugs are regulated under the Drug and Cosmetic Act of 1940 and Rules of 1945. The Department of AYUSH is the regulatory authority that requires manufacturing and marketing licenses. It also discusses definitions, licensing procedures, good manufacturing practices, labeling requirements, and guidelines set by AYUSH.
Quality assurance (QA) is a way of preventing mistakes and defects in manufactured products and avoiding problems when delivering products or services to customers.
The document discusses herbal drug regulation in India. It provides an overview of the types of herbal formulations regulated in India, the advantages of herbal drugs, market statistics, and the various schedules and rules that govern herbal drugs under the Drugs and Cosmetics Act. It also discusses Ayush regulations for herbal drugs, requirements for clinical trials, and issues related to promoting herbal drugs in India. The future prospects section outlines opportunities to improve regulation and development of the herbal drug industry in India.
The European Medicines Agency and regulatory authorities in the EU prepare scientific guidelines to help applicants for herbal medicine marketing authorization. The guidelines provide a harmonized approach across EU states for demonstrating quality, safety, and efficacy of herbal medicines. They include guidelines on good practices for herb cultivation and collection, quality control of herbal substances and preparations, assessing genotoxicity and clinical safety/efficacy of herbal medicines, and public statements on allergic risks and contamination issues.
What is Efficacy
Why Efficacy is required for Herbal products
How Efficacy of Herbal products ensured
What are the various avenues of determining efficacy
Monographs Of Herbal Drugs and Comparative Study In Various Pharmacopoeias.VidyaNani
This document provides a comparison of herbal monographs from three pharmacopoeias: the Ayurvedic Pharmacopoeia of India (API), British Herbal Pharmacopoeia (BHP), and American Herbal Pharmacopoeia (AHP). It outlines the typical contents of monographs from each, such as definitions, descriptions, chemical assays, and qualitative standards. The API focuses on ayurvedic herbs, while the BHP and AHP include Western and traditional medicine herbs. The AHP contains the most therapeutic information, while the API and BHP emphasize identification and purity. Harmonizing formats across pharmacopoeias can help ensure the quality, safety and efficacy of herbal medicines.
The document discusses the International Conference on Harmonisation (ICH), which aims to harmonize technical requirements for pharmaceutical registration across regions to ensure safe, effective, and high quality medicines. It outlines ICH's objectives, organizational structure including working groups and guidelines, and harmonization process. ICH has produced over 50 guidelines on quality, safety, efficacy, and multidisciplinary topics to eliminate duplication in drug development.
Adulteration is the debasement of Genuine materials3.
It may be deliberated or accidentally done.
In crude drugs, this practice includes the substitution of the original crude drug, fully or partially with sub-stranded substances.
Sub-stranded substances include- Inferiority and spoilage.
Inferiority- Natural sub-stranded condition whose natural constituent is below the minimum standard.
Spoilage- sub-stranded condition produced by microbial or pest infestation.
Role of chemical & biological marker.pptxEasy Concept
Standardization and quality control of herbal medicines requires the use of markers. There are three main types of markers - DNA markers, biochemical markers, and chemical markers. DNA markers can be used for authentication of medicinal plants, genetic variation, herbal drug technology, and more. Biochemical markers like isozymes are useful for distinguishing closely related species. Chemical markers indicate quality and can be used for authentication, differentiation, determining harvesting times, and assessing extraction methods. Markers have various applications including identification of adulterants and determination of lead compounds.
WHO to provide technical support to develop a methodology to
monitor or ensure the quality, efficacy and safety of traditional
medicine and its products.
To promote and improve the quality of herbal medicines and
also to reduce the proportion of adverse effect caused by the
poor quality of herbal medicines.
This document discusses the requirements for manufacturing facilities and clinical trials in India according to Schedules M and Y of the Drugs and Cosmetics Rules. Schedule M outlines the good manufacturing practices and requirements for premises, plants, and equipment used in pharmaceutical production. It also discusses facility design aspects like clean surroundings, building facilities, lighting, ventilation, and storage areas. Schedule Y provides the guidelines for conducting clinical trials in India, including the various phases of trials from Phase 0 to Phase IV. It also discusses aspects like informed consent, ethics committee composition, and government facilities for expediting clinical trials.
In this power points viewer will be able to know the meaning of Pharmacopoeia and its coposition. History behind the different pharmacopoeia and popular pharmacopoeia existing world wide in herbal medicines. List of different pharmacopoeias also has been included.
This document outlines guidelines for good agricultural practices in cultivating medicinal plants according to WHO standards. It discusses selecting appropriate plant species and varieties, ensuring quality of propagation materials, optimizing cultivation conditions like climate, soil, irrigation and plant maintenance, proper harvest timing based on plant part and constituent quality, and ensuring trained personnel with knowledge of plant cultivation and hygiene practices are involved in the production process. The goal is to cultivate medicinal plants sustainably and produce high quality raw materials while conserving plant biodiversity and protecting the environment.
Comparison of various herbal pharmacopoeias.pptxEasy Concept
Herbal Pharmacopoeia is a reference book for the preparation of quality medicines published by the authority of a Government and represents qualitative and therapeutic monographs on botanicals
This document discusses and compares herbal drugs and synthetic drugs. It notes that herbal drugs are derived from plants and have been widely used throughout history. They tend to have fewer side effects and be more affordable than synthetic drugs, though they may lack dosage instructions and have interactions. Synthetic drugs are chemically produced substances like marijuana, cocaine, and methamphetamines. They have more consistent quality but can cause issues like violent behavior and memory problems. Both have benefits and risks, and differ in aspects like potency, costs, and targets in the body. Commonly used herbal medicines include glucosamine for joint pain.
This document discusses the growth of herbal drugs as over-the-counter products. It notes that while India is the birthplace of Ayurveda, a popular form of herbal medicine, the domestic herbal drug market in India is much smaller than in Western countries. Herbal drugs can be a safe alternative to prescription drugs for minor illnesses if properly regulated, but lack of standardization and control can pose risks to consumers. Education is needed around the proper use of herbal medications as over-the-counter products to ensure their safe and effective use.
Regulatory requirements for herbal medicines: Herbal medicines are different from other types of medicines. The approval process is also different from other medicines. AYUSH Ministry given guidelines for approval of herbal medicines.
Query Solved
1. Regulatory requirements for herbal medicines
2. Herbal Medicines ke liye regulatory requirements
3. AYUSH ka important role in Herbal medicines launch
4. D and C act role in Herbal medicines
5. What are important steps to launch herbal medicines
This document provides guidelines for monitoring the safety of herbal medicines. It discusses the importance of including herbal medicines in pharmacovigilance systems to understand adverse effects from combined herbal and conventional medicine use. Sources of safety reports include healthcare professionals, consumers, hospitals, and manufacturers. National regulatory agencies are responsible for communicating safety information through various channels to facilitate safe and effective herbal medicine use.
This document discusses the herbal drug industry in India. It provides an overview of:
- The growing trend toward herbal medicines and India's role as a source of medicinal plants
- The scope and size of the herbal drug market in India, which is growing at 20-25% annually
- Infrastructure requirements for herbal drug manufacturing facilities, including space allocation, environmental factors, and quality control processes
- Good manufacturing practices (GMP) that must be followed to ensure quality standards are met
The document discusses the regulatory status of herbal drugs in India. It outlines that herbal drugs are regulated under the Drug and Cosmetic Act of 1940 and Rules of 1945. The Department of AYUSH is the regulatory authority that requires manufacturing and marketing licenses. It also discusses definitions, licensing procedures, good manufacturing practices, labeling requirements, and guidelines set by AYUSH.
Quality assurance (QA) is a way of preventing mistakes and defects in manufactured products and avoiding problems when delivering products or services to customers.
The document discusses herbal drug regulation in India. It provides an overview of the types of herbal formulations regulated in India, the advantages of herbal drugs, market statistics, and the various schedules and rules that govern herbal drugs under the Drugs and Cosmetics Act. It also discusses Ayush regulations for herbal drugs, requirements for clinical trials, and issues related to promoting herbal drugs in India. The future prospects section outlines opportunities to improve regulation and development of the herbal drug industry in India.
The European Medicines Agency and regulatory authorities in the EU prepare scientific guidelines to help applicants for herbal medicine marketing authorization. The guidelines provide a harmonized approach across EU states for demonstrating quality, safety, and efficacy of herbal medicines. They include guidelines on good practices for herb cultivation and collection, quality control of herbal substances and preparations, assessing genotoxicity and clinical safety/efficacy of herbal medicines, and public statements on allergic risks and contamination issues.
What is Efficacy
Why Efficacy is required for Herbal products
How Efficacy of Herbal products ensured
What are the various avenues of determining efficacy
Monographs Of Herbal Drugs and Comparative Study In Various Pharmacopoeias.VidyaNani
This document provides a comparison of herbal monographs from three pharmacopoeias: the Ayurvedic Pharmacopoeia of India (API), British Herbal Pharmacopoeia (BHP), and American Herbal Pharmacopoeia (AHP). It outlines the typical contents of monographs from each, such as definitions, descriptions, chemical assays, and qualitative standards. The API focuses on ayurvedic herbs, while the BHP and AHP include Western and traditional medicine herbs. The AHP contains the most therapeutic information, while the API and BHP emphasize identification and purity. Harmonizing formats across pharmacopoeias can help ensure the quality, safety and efficacy of herbal medicines.
The document discusses the International Conference on Harmonisation (ICH), which aims to harmonize technical requirements for pharmaceutical registration across regions to ensure safe, effective, and high quality medicines. It outlines ICH's objectives, organizational structure including working groups and guidelines, and harmonization process. ICH has produced over 50 guidelines on quality, safety, efficacy, and multidisciplinary topics to eliminate duplication in drug development.
Adulteration is the debasement of Genuine materials3.
It may be deliberated or accidentally done.
In crude drugs, this practice includes the substitution of the original crude drug, fully or partially with sub-stranded substances.
Sub-stranded substances include- Inferiority and spoilage.
Inferiority- Natural sub-stranded condition whose natural constituent is below the minimum standard.
Spoilage- sub-stranded condition produced by microbial or pest infestation.
Role of chemical & biological marker.pptxEasy Concept
Standardization and quality control of herbal medicines requires the use of markers. There are three main types of markers - DNA markers, biochemical markers, and chemical markers. DNA markers can be used for authentication of medicinal plants, genetic variation, herbal drug technology, and more. Biochemical markers like isozymes are useful for distinguishing closely related species. Chemical markers indicate quality and can be used for authentication, differentiation, determining harvesting times, and assessing extraction methods. Markers have various applications including identification of adulterants and determination of lead compounds.
WHO to provide technical support to develop a methodology to
monitor or ensure the quality, efficacy and safety of traditional
medicine and its products.
To promote and improve the quality of herbal medicines and
also to reduce the proportion of adverse effect caused by the
poor quality of herbal medicines.
This document discusses the requirements for manufacturing facilities and clinical trials in India according to Schedules M and Y of the Drugs and Cosmetics Rules. Schedule M outlines the good manufacturing practices and requirements for premises, plants, and equipment used in pharmaceutical production. It also discusses facility design aspects like clean surroundings, building facilities, lighting, ventilation, and storage areas. Schedule Y provides the guidelines for conducting clinical trials in India, including the various phases of trials from Phase 0 to Phase IV. It also discusses aspects like informed consent, ethics committee composition, and government facilities for expediting clinical trials.
In this power points viewer will be able to know the meaning of Pharmacopoeia and its coposition. History behind the different pharmacopoeia and popular pharmacopoeia existing world wide in herbal medicines. List of different pharmacopoeias also has been included.
This document outlines guidelines for good agricultural practices in cultivating medicinal plants according to WHO standards. It discusses selecting appropriate plant species and varieties, ensuring quality of propagation materials, optimizing cultivation conditions like climate, soil, irrigation and plant maintenance, proper harvest timing based on plant part and constituent quality, and ensuring trained personnel with knowledge of plant cultivation and hygiene practices are involved in the production process. The goal is to cultivate medicinal plants sustainably and produce high quality raw materials while conserving plant biodiversity and protecting the environment.
Comparison of various herbal pharmacopoeias.pptxEasy Concept
Herbal Pharmacopoeia is a reference book for the preparation of quality medicines published by the authority of a Government and represents qualitative and therapeutic monographs on botanicals
This document discusses and compares herbal drugs and synthetic drugs. It notes that herbal drugs are derived from plants and have been widely used throughout history. They tend to have fewer side effects and be more affordable than synthetic drugs, though they may lack dosage instructions and have interactions. Synthetic drugs are chemically produced substances like marijuana, cocaine, and methamphetamines. They have more consistent quality but can cause issues like violent behavior and memory problems. Both have benefits and risks, and differ in aspects like potency, costs, and targets in the body. Commonly used herbal medicines include glucosamine for joint pain.
This document discusses the growth of herbal drugs as over-the-counter products. It notes that while India is the birthplace of Ayurveda, a popular form of herbal medicine, the domestic herbal drug market in India is much smaller than in Western countries. Herbal drugs can be a safe alternative to prescription drugs for minor illnesses if properly regulated, but lack of standardization and control can pose risks to consumers. Education is needed around the proper use of herbal medications as over-the-counter products to ensure their safe and effective use.
Ayurvedic Churna is a fine herbal powder made by pulverizing and mixing various medicinal herbs and ingredients according to Ayurveda. Churna has many varieties and is commonly used as an over-the-counter medicine. The Ayurvedic medicine industry in India is growing significantly as people increasingly prefer herbal remedies to synthetic drugs due to safety concerns. The market for Ayurvedic medicines in India is expected to double to Rs. 15,000 crore by 2015 due to rising demand. Churna is widely used due to its availability without a prescription to treat many common ailments.
Roll of pharmacognosy in traditional system of medicineMegha Shah
This document discusses the role of pharmacognosy in various traditional medicine systems including Ayurveda, Siddha, Unani, and allopathy. It provides an overview of each system and explains how pharmacognosy plays an important role in the development and standardization of herbal medicines used in the formulations of each traditional system. Pharmacognosy is involved in the identification, authentication, and quality control of medicinal plants used as the basis for many medicines within these traditional systems.
IRJET- Regulation on Herbal Product used as Medicine around the World: A ReviewIRJET Journal
This document provides an overview of regulations for herbal products used as medicine around the world. It discusses how herbal products are classified and regulated differently in various countries, with requirements ranging from strict regulation for prescription medicines to relatively low control for supplements. The document then reviews the specific regulatory status of herbal medicines in several countries, including India, Uganda, Argentina, Brazil, and Canada. It describes the systems that each country has put in place to regulate manufacturing, safety assessment, registration, and post-marketing surveillance of herbal medicines.
Herbal formulations – current challenges in upgradation and modernization Jasmine Kaur
This document discusses challenges facing the herbal medicine industry in India. It notes that while India has a large number of medicinal plants and a herbal industry worth $10 billion annually, it only has 2% of the global herbal market share due to several key issues. These include a lack of scientific validation and standardization of herbal medicines, limited quality regulation, insufficient evidence-based studies on efficacy and safety, and a lack of pharmacokinetic research on herbal compounds. Addressing these challenges would help India capture a larger share of the global herbal market.
The document summarizes Ayurvedic formulations and the Ayurvedic medicines industry in India. It discusses that Ayurveda uses herbal, mineral, and animal ingredients for medicines. The Ayurvedic medicines market in India was worth Rs. 7,500 crores in 2008 and is projected to double to Rs. 15,000 crores by 2015, reflecting an over 20% compound annual growth rate. The industry consists of raw materials, finished medicines, health supplements, and exports worth Rs. 550 crores annually though India has potential for much higher exports given its botanical resources and traditional knowledge of Ayurvedic medicine.
Scope in Ayurvedic Pharmaceutical Industries.pptxjyoti singh
The document discusses the scope of Ayurveda in pharmaceutical industries. It provides an overview of Ayurveda, including its principles and common dosage forms used. It then outlines the types of Ayurvedic medicines and some popular formulations. The document discusses the Ayurvedic pharmaceutical industry and top companies. It also covers opportunities in the industry, such as production management, quality control, research, and government roles. Finally, it discusses the growth of the Ayurvedic market and establishment of the WHO Global Centre for Traditional Medicine in India.
Herbs, Herbal Drugs
Present Scope of Herbal Drug Industry
Scope of Herbal Drug Medicine and Industry
Indian Herbal Industry
International Scope of Herbal Medicines
World Wide Herbal Trade
Overview on plant based industries and research institutions in India
List of few herbal drug industries in India
List of few herbal research institution/ centres in India
General Introduction to Herbal Industry
Herbal drugs industry: Present scope and future prospects.
A brief account of plant based industries and institutions involved in work on medicinal and
aromatic plants in India.
AYUSH IN INDIA 2021( ministry of Ayush) .pdfAmit432037
The document discusses the Ministry of Ayush in India and the traditional medicine systems it oversees. It was created in 2014 to promote Ayush systems including Ayurveda, Yoga, Naturopathy, Unani, Siddha, Sowa Rigpa and Homeopathy. The ministry is committed to scientifically validating these traditional systems and presenting them using modern scientific approaches. It then provides details on the various Ayush systems, including descriptions of Ayurveda, Unani, and their history, fundamental concepts and approaches to health.
The presentation consists all information relevant to indigenous medical system of india, commonly called AYUSH .
Also includes other traditional practices
Author : vijay amalaraj
simonvijay004@gmail.com
The document discusses regulations for herbal medicines in India. It notes that herbal medicines, also known as Ayurvedic, Siddha, and Unani (ASU) medicines, are regulated under the Drugs and Cosmetics Act of 1940 and Rules of 1945. The Ministry of AYUSH is the regulatory authority that oversees licensing for manufacturing and marketing of herbal drugs. ASU medicines are considered safe due to their long history of use in India, so no safety or efficacy studies are required for approval. However, standardization of raw materials is a key issue given potential for contamination. The Drug Technical Advisory Board and Drug Consultative Committee provide regulatory oversight of the herbal drug sector.
National Formulary of Unani Medicine, Part 2, Volume 1 is standard compound drugs pharmacopia of unani medicine, Published by Department of Ayush, Ministry of Health and HFW, Government of India IN August 2007
Herbal medicines are popular because of experience and the abundant
availability of plants in India due to its varied climatic zones. India has
around 45,000 species of plants, out of which 15,000–20,000 plants have
proven medicinal value.
Standardization of ayurvedic products includingMohit Bishnoi
1. The document discusses the need to standardize Ayurvedic products and implement Good Manufacturing Practices (GMP) in the Ayurvedic industry.
2. It notes that while classical Ayurvedic texts provide guidelines, it is not possible for modern manufacturers to strictly follow them, necessitating GMP standards.
3. The author argues that implementing GMP and incorporating modern research tools can help ensure Ayurvedic medicines are safe, effective, and consistent, improving their acceptance in India and globally.
The document discusses Ayurvedic medicine, including its foundations, doshas, treatments to balance doshas, safety, regulation, and innovations. It notes that Ayurveda focuses on balance and wellness rather than disease, uses diet, herbs, and breathing. It describes the five elements and three doshas that make up the human body. Recent innovations include patents on Ayurvedic formulations, collaboration on clinical trials, and use of herbs in cancer treatment. However, some herbs may be toxic if misused and require more research on safety. Regulation focuses on product quality rather than efficacy.
The document discusses regulatory issues for Ayurveda, Siddha, and Unani (ASU) drugs in India. It outlines that the Drugs and Cosmetics Act of 1940 and Rules of 1945 regulate traditional medicines and require licensing for manufacturing. The Drug Technical Advisory Board (ASU DTAB) and Drug Consultative Committee (ASU DCC) advise the government on technical and regulatory matters related to ASU drugs. Their roles include recommending good manufacturing practices, reviewing pharmacopoeias, and ensuring uniform drug regulation across India.
Traditional herbal medicine plays an important role in healthcare due to the inaccessibility of modern medicines for many. The World Health Organization has endorsed the safety and effectiveness of herbal medicine. This has led to a need to regulate practices like manufacturing, processing, sale and supply of herbal medicines. While herbal medicines make up a $300 million market in India compared to $2.5 billion for modern medicines, over 250,000 practitioners are registered in Ayurvedic medicine and it is used when modern treatments are unavailable. However, issues like lack of standardization of traditional preparations and reckless exploitation of medicinal plants present challenges.
General Introduction to Herbal Industry.pdfSamerPaser
Know about the present scope and future prospects of herbal drug industry
2. Know about the various plant based industries and institutions
3. Know about the various industries involved in work on medicinal and aromatic plants in
India
4. Know about the Schedule-T and its objectives
5. Know about the components of GMP and various infrastructural requirements of
working space
The document provides guidelines for cluster randomized trials. It discusses that CRTs involve randomizing clusters, such as communities or medical practices, to different intervention groups rather than randomizing individuals. Researchers should determine research participants, feasibility of informed consent, and ethical acceptability of a no-intervention group. Permission may need to be obtained from gatekeepers when a cluster's interests are involved. Informed consent is generally required but a waiver may be granted when consent is virtually impossible, such as for interventions directed at entire communities.
The autonomic nervous system is an involuntary system that controls and modulates functions of visceral organs like the heart and digestive system. It has two divisions - the sympathetic and parasympathetic nervous systems. The autonomic nervous system uses neurotransmitters like acetylcholine, dopamine, norepinephrine, glutamate, GABA, and serotonin to transmit signals between neurons and target cells. Neurotransmission in the autonomic nervous system follows several steps - impulse conduction, transmitter release from synaptic vesicles, transmitter action on postjunctional membranes, and destruction or removal of transmitters after use.
Dapsone is a sulfone antibiotic synthesized in 1908 that is used to treat leprosy and other conditions. It works by inhibiting the biosynthesis of folate. Dapsone began being used to treat leprosy in 1945 and is included on the WHO's list of essential medicines. It is commonly used in combination with other drugs in multiple drug therapy (MDT) for leprosy. Dapsone is absorbed and distributed throughout the body, metabolized in the liver, and eliminated through urine and feces. Common side effects include mild anemia, rashes, and nausea. Recent developments include a topical gel formulation for acne.
This document describes several models used to study anti-ulcer drugs: the pylorus ligation model in rats, immobilization stress model, cold water immersion stress model, and indomethacin-induced ulcer model. For each model, it provides details on the purpose, procedures, evaluation methods, and critical assessments. The pylorus ligation and immobilization stress models are used to study drugs with various mechanisms of action and resemble factors in human ulcer pathogenesis. The cold water and indomethacin models are described as useful for final drug evaluation but may not be fully inhibited by H2 receptor antagonists.
Tuberculosis is a chronic infectious disease caused by the bacterium Mycobacterium tuberculosis that primarily affects the lungs. It spreads through the air and is one of the top infectious killers worldwide. Those at highest risk include those with weakened immune systems, living in areas with high TB rates, abusing alcohol or tobacco, or living with an infected individual. The bacteria are inhaled, travel to the lungs, and can spread throughout the body. Most infections remain latent without symptoms, but active disease can cause coughing, weight loss, fever and other signs. Diagnosis involves sputum tests, chest imaging and tuberculin skin tests. Treatment requires multiple antibiotic drugs over several months to prevent drug resistance. New vaccines and drug
A controlled trial for safety and immunogenicity Of Zika purified inactivated...ShaistaAhmed8
To assess the safety and immunogenicity of Zika purified inactivated virus vaccine in humans up to 52 weeks of follow-up when given via standard or accelerated vaccination schedules.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...rightmanforbloodline
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...rightmanforbloodline
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Versio
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Regulation of herbal drugs
1. Regulation of Herbal Drugs
Presented By:
Shaista Ahmed
M.Sc. Clinical Research
2nd Semester
Jamia Hamdard
2. INTRODUCTION
The use of plants for healing purposes predates recorded history and forms the origin
of much of modern medicine.Medicinal plants based traditional systems of medicines
are playing important role in providing health care to large section of population,
especially in developing countries. Indian Systems of Medicine are among the well
known global traditional systems of medicine.
Most of the effective drugs were plant-based example aspirin (from willow
bark),quinine(from cinchona bark) and morphine(from the opium poppy).The
development of drugs from plant continues with drug companies engaged in large
scale pharmacologic screening of herbs.
India has the unique distinction of having five recognized systems of medicine in this
category. They are-Ayurveda, Siddha, Unani, Naturopathy and Homoeopathy.
3. What are Herbal Drugs?
Herbal Medicines are plant-derived materials or products with
therapeutic or other human health benefits which contain either raw or
processed ingredients from one or more plants.
4. Advantages of Herbal Drugs:
They do not have negative side effects.
They are very effective as compared to synthetic cosmetics.
Easily available in large variety and quantity.
Easily manufacture and cheap in cost.
5. Ayurveda
The ancient Indian medical system also known as Ayurveda is based on ancient
writing that rely on “natural” and holistic approach to physical and mental health.
Ayurveda medicine is one of the world’s oldest medical system and remains one
of the traditional health care systems.
According to the World Health Organization about 70-80% of the world
populations rely on nonconventional medicines mainly of herbal sources in their
healthcare.
The comprehensive knowledge of the basic ideologies of Ayurveda is poorly
acceptable scientifically due to lack of evidence.
6. Unani
Unani Medicine can be characterized by the works of its practitioners or hakims who
relied on natural healing based on principles of harmony and balance , uniting the
physical , mental and spiritual domain.
A traditional system of healing and health maintenance observed in south asia . The
origins of unani medicine are found in the doctrines of the ancient Greek physicians
Hippocrates and Galen
The treatments for chronic ailments and diseases of skin, liver, musculo-skeletal and
reproductive systems, immunological and lifestyle disorders have been found to be
highly effective and acceptable.
7. Hakim Abdul Majeed made valuable contribution in unani medicine .He established
Hamdard Laboratories in 1906 ,it is a Unani pharmaceutical company in india ,Delhi .It
was established and became a waqf (non-profitable trust) in 1948. After the sad demise
of Hakeem Abdul Majeed his son Hakeem Abdul Hameed(1908-1999) tried his best to
bring unani system of medicine on modern scientific lines
Some of its most popular products include Sharbat Rooh Afza, Safi, Roghan Badam
Shirin, Sualin, Joshina and Cinkara. It is associated with Hamdard Foundation, a
charitable educational trust.
Hakim Abdul Hameed
8. Naturopathy
(Art of natural healing)
A system of alternative medicine based on the theory that diseases can be successfully
treated without the use of drugs, by techniques such as control of diet, exercise, and
massage.
Naturopathy cures patients suffering from chronic ailments in comparatively less time than
any other form of medicine.
Naturopathic doctors treat their patients holistically i.e. taking into consideration their
individual biochemistry, bio mechanics and emotional predispositions.
Some important treatments of naturopathy are: Mud pack, Mud Bath, Spinal Bath,, Steam
Bath, Sun Bath, Magnet Therapy, Acupuncture, Acupressure, Physiotherapy
9. Siddha
Siddha medicine is one of the oldest traditional systems of medicine practiced in southern
part of India.
Siddhar Agasthyar is considered as the founding father of this medical system and there
are 18 prominent siddhars who are the main contributors to this system of medicine.
It has holistic approach and covers physical, psychological, social and spiritual well being
of an individual. Siddha medicines use Mooligai (herbs), Thathu (minerals) and Jeeva
(animal products) as their sources.
Diagnosis of disease in siddha is made on the basis of Envagaithervu (Eight parameters),
of which nadi (pulse reading) is given special importance. It helps to find out the
imbalanced or predominating kuttram (humor).
10. Homeopathy
The word ‘Homeopathy’ is derived from two Greek words hómoios (similar) and páthos
(suffering).
Homeopathy is a distinct medical specialty being practiced across the world. It is a
recognized medical system in India through the Homeopathy Central Council Act, 1973.
The system has blended well into the ethos and traditions of the country that it has been
recognized as one of the national systems of medicine.
Homeopathic remedies are used by the public for viral diseases, allergic conditions, skin
disorders , various women and children diseases, hormonal disorders, pain and palliative
care, infertility ,as an adjunct/ adjuvant in Cancer, COPD, Diabetes and its complications.
In preventive care, Homeopathic medicines are used on a unique concept of Genus
epidemicus.
11. REGULATION IN INDIA
Herbal drugs are regulated under the Drug and Cosmetic Act ( D and C) 1940 and Rules
1945 in india , where regulatory provisions for Ayurveda,Unani,Siddha medicines are
clearly laid down.
India has made GMP mandatory for manufacturing of Ayurvedic, Siddha and Unani
Medicines by incorporation of revised Schedule T in the year of 2003.
Department of AYUSH is the regulatory authority and mandate that any manufacturing
or marketing of herbal drugs have to be done after obtaining manufacturing license .
12. AYUSH REGULATES
Department of AYUSH, ICMR and CSIR work together to achieve safe,
effective AYUSH products for the identified diseases and to develop new drugs.
AYUSH objectives are to control drug quality, laying down pharmacopoeial
standards, overseeing working of Pharmacopoeial Laboratory of Indian Medicines
(PLIM), partnership with the Quality Council of India (QCI) and to oversee
functioning of Indian Medicine Pharmaceutical Company Limited (IMPCL).
AYUSH also controls enforcement of Good Manufacturing Practices (GMP),
setting up of common facilities following the Cluster approach and implementing
the scheme for Drug Quality Control.
13. New Regulatory guidelines by AYUSH
GAPs-Good Agriculture Practice . To promote the agriculture practice of herbal
drugs.
GACPs-Good Agriculture collection practice . For cultivation and collection of
herbal drugs.
GAFCPs-Good Agriculture and field collection practice . For better field selection
and harvesting
15. Application for license to manufacture Drugs
An application for the grant or renewal of a license to manufacture for sale any
Ayurvedic,siddha,unani drug shall be made in Form 24-D to the license authority
along with fee of rupees one thousand.
16. Form of Licence to manufacture Drugs
Subject to the conditions of rule 157 being fulfilled,a license to manufacture for
sale any Ayurvedic,Siddha or unani drugs shall be issued in Form 25-D.The
license will be issued within a period of 3 months from date of receipt of the
application.
17. RULE 157
The manufacture of drug shall be carried out in condition mentioned in Schedule T
The manufacturing of drugs shall be conducted under the supervision of competent
technical staff consisting atleast one person.
The competent technical staff to direct and manufacture of ayurvedic drugs shall have
qualifications in Ayurveda as if siddha drugs and unani drugs have qualifications in
siddha or unani.
18. Schedule T, Drugs and Cosmetics Act
Schedule T for Good Manufacturing practice:
To manufacture good quality Ayurvedic, Siddha and Unani medicines Good
Manufacturing practices have been made mandatory by incorporation of revised
Schedule T in the year of 2003 (Govt. of India, 2005 ). Important features of Schedule T
are as follows:
i)Raw materials to be used in manufacture of medicines must be authentic, of prescribed
quality and free from contamination.
ii)Manufacturing process is as prescribed to maintain the standard.
iii)Adequate quality control measures to be adopted.
iv)Drugs released for sale shall be of acceptable quality.
19. A form of loan licence to manufacture drugs
A loan license to manufacture for sale of any drug shall be issued in form 25-E in
which state government may approve in thus behalf
20. Pradhan Mantri Jan Arogya Yojna
• This is a flagship scheme of the indian governments’s National Health Policy
which aims to provide free health coverage at the secondary and tertiary level to
its bottom 40% poor and vulnerable population.
• It offers a health cover to nearly 10.74 crore poor families.
• The Ayush Ministry has proposed inclusion of 19 Ayurvedic,Yoga,unani,siddha
and Homeopathy treatment packages in the cashless health insurance scheme PM-
JAY.
• This collaboration address the untapped potential of integration of AYUSH system
with modern medicine.
21. Schedules For Herbal Drugs In CDSCO
SCHEDULE E-List of poisonous substances under the Ayurvedic, siddha and
unani system of medicine.
SCHEDULE T-Under Schedule T of the drugs and cosmetics act 1940 the
government has made it mandatory for all manufacturing units to adhere to GMP
SCHEDULE Q-No cosmetics shall contain Dyes,Colours and Pigments.
22. IPR ISSUES of herbal drugs
Growing awareness of Ayurvedic medicines and formulations has led to several conflicts
with western pharmaceutical companies who are taking the lead from Ayurvedic
medicines and patenting them in their own name . By patenting our own herbs we can
protect Indian Intellectual Property .So to protect India has established a central authority
that is “National Biodiversity Authority” to monitor and control foreign access to Indian
biological resources including traditional medicines.
India’s patent laws with the Amendment Act of 2005 which contain provision for
mandatory disclosure of source and geographical origin of the biological materials used
in the invention while applying for Patent.
Development of database called Traditional Knowledge Digital library(TKDL), a
collaboration project of (CSIR) (AYUSH) to protect Indian traditional medicinal
knowledge and prevent its misappropriation at International Patent Offices.
23. Clinical trial phases
Phase I studies may not be necessary.
Need for testing its toxicity in animals has been considerably reduced.
Toxicity study may not be needed for phase-II trial unless reports suggesting
toxicity/herbal preparation is to be used for more than 3months.
Larger multi centric phase-III trial is subsequently planned based on results of phase-II
study.
These trials have also got to be approved by appropriate scientific and ethical
committee.
24. Regulatory Requirements for Clinical
Trials of Herbal Drugs
The procedures laid down by the office of the DCGI for allopathic drugs should
be followed for all traditional and herbal products to enter into clinical trials for
any therapeutic condition.
Co-investigators of the expert group are from the associations of physicians from
the concerned system for designing and evaluating the study.
25. Statics of MARKETS
Increased interest had significally contributed to the economic growth of the
Medicinal plant sector.
The global market potential of Aloe vera used to treat burns and added to skin
cream and cosmetics was estimated in the billions of dollars.
70% of export from the herbal sector consists largely of raw materials and is
estimated to be Rs 10 billion per annum.
It is estimated that nearly 960 plant species are used by the indian herbal
industry,and the turnover of the industry is more than Rs 80 billion.
One startup name Sparsh healthcare and wellness completely focusing on AYUSH
products for the treatment of patients.
26. FUTURE PRESPECTIVE
Promotion of AYUSH education with emphasis on technical education in
AYUSH.
Popularization and promotion of indian system of medicine in foreign
countries.
Elaborate guidelines on quality control of herbal medicines.
Develop reference standard for market-based analysis for all the plants used in
medicinal preparations.
Awareness regarding GAP,GACP,GSP among growers and manufactures.
Development of unified protocols , defined timelines and specific guidelines
defining the meeting with regulators.
Financial assistance.